Abstract
N-methyl-d-aspartate receptors (NMDARs), a major subtype of glutamate receptors mediating excitatory transmission throughout the central nervous system (CNS), play critical roles in governing brain function and cognition. Because NMDAR dysfunction contributes to the etiology of neurological and psychiatric disorders including stroke and schizophrenia, NMDAR modulators are potential drug candidates. Our group recently demonstrated that the major brain cholesterol metabolite, 24S-hydroxycholesterol (24S-HC), positively modulates NMDARs when exogenously administered. Here, we studied whether endogenous 24S-HC regulates NMDAR activity in hippocampal slices. In CYP46A1−/− (knockout; KO) slices where endogenous 24S-HC is greatly reduced, NMDAR tone, measured as NMDAR-to-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) excitatory postsynaptic current (EPSC) ratio, was reduced. This difference translated into more NMDAR-driven spiking in wild-type (WT) slices compared with KO slices. Application of SGE-301, a 24S-HC analog, had comparable potentiating effects on NMDAR EPSCs in both WT and KO slices, suggesting that endogenous 24S-HC does not saturate its NMDAR modulatory site in ex vivo slices. KO slices did not differ from WT slices in either spontaneous neurotransmission or in neuronal intrinsic excitability, and exhibited LTP indistinguishable from WT slices. However, KO slices exhibited higher resistance to persistent NMDAR-dependent depression of synaptic transmission induced by oxygen-glucose deprivation (OGD), an effect restored by SGE-301. Together, our results suggest that loss of positive NMDAR tone does not elicit compensatory changes in excitability or transmission, but it protects transmission against NMDAR-mediated dysfunction. We expect that manipulating this endogenous NMDAR modulator may offer new treatment strategies for neuropsychiatric dysfunction.
Keywords: 24S-hydroxycholesterol, NMDAR, hippocampal slice, CYP46A1 knockout mice
n-methyl-d-aspartate receptors (NMDARs) are nonselective cation channels that are gated by the neurotransmitter glutamate and that exhibit voltage dependence and high calcium permeability. Normal NMDAR function is required for proper synapse formation, maturation, elimination, and plasticity (Cohen and Greenberg 2008; Hunt and Castillo 2012; Sanz-Clemente et al. 2013). Dysfunction of NMDARs has significant impact on brain function and cognition and has been implicated as a major contributor to several neurological and psychiatric diseases, including epilepsy, Alzheimer's disease, depression, stroke, and schizophrenia (Ghasemi and Schachter 2011; Hardingham and Bading 2010; Lau and Zukin 2007; Paoletti et al. 2013). Interestingly, NMDAR hypofunction is linked to psychotic symptoms associated with schizophrenia (Coyle 2006; Coyle et al. 2010; Tamminga 1998). Therefore, elevating NMDAR activity may be an effective treatment for key symptoms of schizophrenia (reviewed in Coyle et al. 2010). On the other hand, there is longstanding interest in reducing NMDAR function as a therapeutic strategy for excitotoxic injury from stroke and from neurodegenerative diseases (Danysz and Parsons 2012; Lai et al. 2014). Thus, both downregulation and upregulation of NMDAR function may have a place in the therapeutic repertoire.
NMDARs exhibit multiple binding sites for endogenous ligands and regulators, through which channel activity can be positively and negatively regulated. Besides its major agonist and coagonist-glutamate and glycine, NMDAR activity is allosterically modulated by a variety of modulators, including polyamines, redox agents, arachidonic acid, and neurosteroids (Vyklicky et al. 2014; Yamakura and Shimoji 1999). Neurosteroids, produced endogenously in the brain, have rapid modulatory effects on γ-aminobutyric acid receptors (GABARs) and NMDARs to influence neuronal excitability and plasticity (Benarroch 2007; Paul and Purdy 1992), with resulting effects on learning and memory (Vallee et al. 2001a; Vallee et al. 2001b). Pregnenolone sulfate (PREGS) is an endogenous neurosteroid that enhances NMDAR-dependent synaptic plasticity and behaviors (Flood et al. 1992; Mathis et al. 1994; Sliwinski et al. 2004; Smith et al. 2014). However, the importance of its neuromodulatory role under physiological conditions is still questionable, given the extremely low level of endogenous PREGS in the rodent brain (Liere et al. 2009; Wu et al. 1991).
We recently identified a novel class of positive NMDAR modulators, 24S-hydroxycholesterol (24S-HC) and synthetic analogs (Paul et al. 2013). Application of 24S-HC or the synthetic analogs, SGE-201 and SGE-301, directly enhances NMDAR currents in hippocampal neurons and HEK cells in culture. Moreover, synaptic and cognitive deficits induced by NMDAR channel blockers were reversed following SGE-201 or SGE-301 treatment in hippocampal slices and in vivo (Paul et al. 2013). 24S-HC is the major brain cholesterol metabolite and is produced by cholesterol 24-hydroxylase (CYP46A1), a neuron-specific enzyme localized to dendrites (Russell et al. 2009). The abundant level of endogenous 24S-HC, up to several micromolar (30–60 ng/mg tissue) in adult brain, suggests that it may be critical for maintaining normal NMDAR tone under physiological conditions (Meljon et al. 2012; Smith et al. 1972). Based on this, we hypothesize that endogenous 24S-HC contributes to normal NMDAR function, and manipulating 24S-HC level may regulate NMDAR tone, thus offering a potential strategy for treating physiological abnormalities resulting from NMDAR hypofunction and hyperfunction.
The endogenous 24S-HC concentration can be up- or downregulated by genetic alteration of CYP46A1 expression. Mice lacking CYP46A1 enzyme have normal development and basal brain function but exhibit deficits of synaptic plasticity, learning, and memory (Kotti et al. 2006; Kotti et al. 2008; Russell et al. 2009). On the other hand, mice overexpressing CYP46A1 enzyme showed increased levels of synaptic proteins in hippocampus, as well as enhanced memory retention in aged female mice (Maioli et al. 2013). Despite circumstantial evidence from the above studies, the direct effect of endogenous 24S-HC on NMDAR function has not previously been explored. In the present study, we tested whether reduction of endogenous 24S-HC leads to NMDAR hypofunction in mouse hippocampal slices. Results from our studies suggest that endogenous 24S-HC does indeed regulate NMDAR tone without detectable secondary/compensatory effects on neurotransmission. The actions of endogenous 24S-HC are apparently not saturated and contribute to a form of NMDAR-dependent synaptic depression induced by pathophysiological conditions in hippocampal slices.
MATERIALS AND METHODS
Slice preparation.
Hippocampal slices were prepared from postnatal day 18 (P18) to P32 wild-type (WT) or CYP46A1−/− (KO) mice. WT C57Bl/6J or KO mice on a similar genetic background (Jackson Laboratories) were used in all studies. Slices for all studies were cohort and age matched to the extent possible. In accordance with protocols approved by the Washington University Animal Studies Committee, mice were anesthetized with isoflurane and decapitated. The brain was removed and glued onto a Leica VT1200 specimen holder. Sagittal (300 μm) slices were cut in ice-cold, modified artificial cerebrospinal fluid (ACSF) (in mM: 87 NaCl, 75 sucrose, 25 glucose, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, equilibrated with 95% oxygen-5% CO2 plus 0.5 CaCl2, 3 MgCl2; 320 mosmol). Slices were then incubated at 32–34°C for 30 min in choline-based ACSF (in mM: 92 choline chloride, 25 glucose, 30 NaHCO3, 2.5 KCl, 1.2 NaH2PO4, 20 HEPES, 2 thiourea, 5 Na ascorbate, and 3 Na pyruvate, 2 CaCl2 and 1 MgCl2, equilibrated with 95% oxygen-5% CO2; 300 mosmol), and subsequently stored at room temperature in regular ACSF (in mM: 125 NaCl, 25 glucose, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, equilibrated with 95% oxygen-5% CO2 plus 2.6 CaCl2, 1.2 MgCl2; 310 mosmol), allowing for at least 1 h recovery prior to experiments. Except for noted exceptions, drugs were obtained from Sigma (St. Louis, MO).
Analysis of endogenous 24S-HC level in mouse hippocampal tissues and slices.
Three mouse brains from each group of WT or CYP46A1 KO animals were harvested. Each brain was bisected into two hemispheres. Hippocampi from one of the hemispheres were frozen at −70°C immediately. The other hemisphere from the same brain was cut into 300-μm hippocampal slices and stored in ACSF at room temperature for 5–6 h before being frozen at −70°C. For measurement of 24S-HC level, the frozen tissue and slice samples were homogenized with 300 μl of PBS buffer. 24S-HC in 25 μl (50 μl of the sliced hippocampus tissue homogenate) of the whole hippocampus tissue homogenate was extracted with 200 μl of methanol. Deuterated 24S-HC (24S-HC d7: 100 ng) was used as an internal standard and was added to the samples before extraction. The four-point calibration standards of 24S-HC, containing 24S-HC d7, were also prepared for the absolute quantification. 24S-HC and 24S-HC d7 were derivatized to N, N-dimethylglycinate (DMG) to increase the mass spectrometry (MS) sensitivity. Sample analysis was performed with a Shimadzu 20AD HPLC system, a LeapPAL autosampler coupled to a triple quadrupole mass spectrometer (API 4000) operated in multiple reaction monitoring (MRM) mode. The positive ion electrospray ionization (ESI) mode was used for detection of 24S-HC and deuterated 24S-HC d7. The study samples were injected in duplicate for data averaging. Data processing was conducted with Analyst 1.5.1 (Applied Biosystems). Bicinchoninic acid (BCA) assay was performed on all the tissue samples for protein determination. The values reported for the hippocampal samples were normalized to protein content.
Whole cell patch-clamp recording.
Slices were transferred to a recording chamber and continuously perfused with oxygenated ACSF at 2 ml/min. Experiments examining tonic NMDAR activation upon glutamate transporter inhibition and LTP/OGD studies were performed at 30–32°C. Other recordings were performed at 23–25°C. For measuring dual-component EPSCs, picrotoxin (PTX, 100 μM) and d-serine (10 μM) were included in extracellular solutions to inhibit GABA-mediated neurotransmission and to enhance NMDAR-mediated currents. In some experiments, 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Bristol, UK) at 10 μM was included in extracellular solutions to isolate NMDAR EPSCs. For isolating AMPAR EPSCs or GABAR inhibitory postsynaptic currents (IPSCs), 100 μM PTX and 50 μM d-(−)-amino-5-phosphonopentanoic acid (d-APV; Tocris) or 10 μM NBQX and 50 μM d-APV were included in extracellular solutions, respectively. For measuring tonic NMDAR current, 100 μM PTX, 10 μM NBQX, and 10 μM d-serine were included in extracellular solutions. dl-threo-β-Benzyloxyaspartic acid (TBOA) (50 μM, Tocris) was bath-applied to evoke tonic NMDAR current. (+)-5-Methyl-10,11-dihydro-5H-dibenzo[a, d]cyclohepten-5,10-imine (MK-801; 40 μM, Tocris) was bath-applied to examine the time constant of NMDAR channel block. For measuring neuronal intrinsic excitability, experiments were performed in the presence of 100 μM PTX, 10 μM NBQX, and 50 μM d-APV to block synaptic transmission.
Somatic, whole cell patch-clamp recordings were performed using standard differential contrast interference microscopy under infrared illumination. In the experiments where PSCs or PSPs were evoked, a small cut was made to separate CA1 from CA3 area to prevent recurrent synaptic activity. CA1 pyramidal cells were identified on an upright Nikon Eclipse E600FN microscope and a QImaging camera controlled with QCapture (QImaging, Surrey, Canada). Somatic whole cell recordings were made with borosilicate patch pipettes (World Precision Instruments, Sarasota, FL; Sutter Instruments, Novato, CA), having open tip resistance of 3–7 MΩ. After a whole cell configuration was established, cells were allowed to fill with the intracellular solution for ∼5 min. Intracellular EPSCs or EPSPs were evoked by a stimulating electrode placed in striatum radiatum, ∼50 μm away from CA1 cell body layer and 50–100 μm away from the recorded cell. Stimulation was applied at 0.033–0.05 Hz, with 0.1-ms pulse width. Recordings were obtained using a MultiClamp 700B amplifier (Molecular Devices; Sunnyvale, CA) and pClamp 10.4 software (Molecular Devices).
For voltage-clamp experiments, the intracellular pipette solution contained (in mM) 120 cesium methanesulfonate, 20 HEPES, 10 EGTA, 2 MgATP, 0.3 Na2GTP, and 5 QX-314; pH was adjusted with CsOH to pH 7.25 (290 mosmol). Cells were voltage-clamped at −30 mV, −70 mV, and 0 mV for evoked NMDAR EPSCs (including dual-component EPSCs), isolated AMPAR EPSCs, and GABA IPSCs, respectively. For measuring sEPSCs and sIPSCs, cells were voltage-clamped at −70 mV and 0 mV, respectively, and data were acquired in gap-free mode. For measuring tonic NMDAR current, cells were voltage-clamped at −30 mV.
For current-clamp experiments, the intracellular pipette solution contained (in mM) 140 K-gluconate, 4 MgCl2, 10 HEPES, 0.4 EGTA, 4 MgATP, 0.3 Na2GTP, and 10 phosphocreatine; pH was adjusted with KOH to pH 7.25 (290 mosmol). For measuring intrinsic excitability, CA1 neurons were initially maintained at −74 mV with constant current injection when necessary, and 500-ms current steps with 100 pA increment intervals were injected somatically, with a range of 0–800 pA. Current threshold was defined as the minimal injected current needed for firing a single spike. For measuring dual-component EPSPs and the resultant firing, a repetitive stimulation protocol containing 10 pulses at 50 Hz was applied to promote dual-component EPSPs. Neurons were initially maintained at −65 mV with constant current injection before application of stimulation. Stimulation intensity was adjusted to evoke 5–6 spikes (half of the pulse number) for each cell. Somatic bridge balance and pipette capacitance were adjusted using MultiClamp 700B Commander software.
Data were acquired at 100 kHz, filtered at 4 kHz using an 8-pole Bessel filter, and digitized using a DigiData1550 16-bit A/D converter (Molecular Devices). Somatic access resistance was monitored continuously, and cells with unstable access resistance (>20% change) were excluded from analysis. SGE-301 obtained from SAGE Therapeutics (Cambridge, MA) was dissolved at 1.25 mM in 100% DMSO to make concentrated stock solutions.
Field EPSPs (fEPSPs), long-term potentiation (LTP), and oxygen-glucose deprivation (OGD) recordings.
The hippocampus was dissected from postnatal day 28 (P28)–P32 WT or KO mice under isoflurane anesthesia. Slices (400 μm) were cut from the septal hippocampus with a rotary slicer in ACSF containing (in mM) 124 NaCl, 5 KCl, 2 MgSO4, 2 CaCl2, 1.25 NaH2PO4, 22 NaHCO3, 10 glucose, bubbled with 95% oxygen- 5% CO2 at 4–6°C (296 mosmol). After recovering for at least 1 h at 30°C, hippocampal slices were transferred to a submerged recording chamber with continuous bath perfusion of ACSF at 2 ml/min at 30°C. Extracellular recordings were obtained from the apical dendritic layer of the CA1 region elicited with 0.1 ms constant-current pulses through a bipolar stimulating electrode placed in stratum radiatum. During an experiment, excitatory postsynaptic potentials (EPSPs) were monitored using a half-maximal stimulus based on a baseline input-output curve. For LTP studies, tetanic stimulation (100 Hz for 1 s) was delivered to a bipolar extracellular stimulating electrode placed in the Schaffer collateral pathway. fEPSPs were monitored for 60 min subsequent to the tetanus. As a measure of LTP, the slope of the fEPSP 50–60 min following tetanic stimulation was compared with the fEPSP slope for the 10 min immediately preceding tetanic stimulation. For OGD experiments, ASCF was replaced with identical fluid without glucose and gassed with 95% N2-5% CO2 for 20 min. An input-output curve was repeated 90 min following OGD for statistical comparisons of changes in EPSP slopes at half-maximal intensity. In some experiments, KO slices were treated with 1 μM bath SGE-301 for 20 min before OGD and during the 20 min OGD challenge. SGE-301 was then washed out after OGD challenge.
Data analysis.
Data analysis was performed in Clampfit 10.4 (Molecular Devices). For measurement of NMDAR/AMPAR, NMDAR current averaged from 10 traces was estimated as mean value at 50–55 ms following peak of dual-component EPSC (Hestrin et al. 1990), while AMPAR current averaged from 10 traces was calculated as EPSC peak amplitude following 5 min d-APV (50 μM) treatment. For measuring TBOA-induced tonic NMDAR current, the mean value of holding current 12 s immediately preceding TBOA application was calculated as the baseline, and the mean current at the end of a 6 min TBOA application was subtracted from the baseline. For estimating MK-801-induced decay of tonic NMDAR current, the decay tau of current was calculated by fitting the current trace to a single-exponential decay function. For calculating SGE-301 effects on synaptic currents, baseline EPSC or IPSC peak amplitude was determined from averaging 20 traces before SGE-301 bath application. After 6 min SGE-301 wash-in, EPSC or IPSC peak amplitude was averaged from the following 20 traces, and level of potentiation was calculated by normalizing this value to baseline. For comparing intrinsic excitability, spike firing threshold was determined as the minimal intensity of injected current needed for eliciting the first spike. Frequency of sEPSCs and sIPSCs was calculated using Mini analysis software (Synaptosoft; Fort Lee, NJ). For determining levels of OGD-induced synaptic depression, slope of fEPSP calculated at 90 min following OGD was normalized to fEPSP slope at the 10 min baseline.
Student's independent, two-tailed t-test was performed to determine statistical significance between the means of two groups. For data normalized to baseline (percentage changes) and for data sets that failed to pass the Shapiro-Wilk normality test, two-tailed nonparametric Wilcoxon tests were performed. Mann-Whitney tests were used for nonpaired comparison of drug effects between two groups, and a Kruskal-Wallace test with Dunn's post hoc analysis were used to compare nonparametric data with >2 groups (see text and figure legends). For detection of drug and genotype effects within an experiment, a two-way ANOVA and Bonferroni post hoc analysis were performed. Significance is described at the level of P ≤ 0.05, P ≤ 0.01, and P ≤ 0.001. Values are presented as means ± standard error of the mean (SE).
RESULTS
Ex vivo slices retain similar 24S-HC levels as fresh tissue.
The level of endogenous 24S-HC is dramatically reduced in mice genetically deficient in CYP46A1 (Russell et al. 2009). To confirm the reduction of endogenous 24S-HC in the CYP46A1 KO mice used in our study, we analyzed and compared 24S-HC level in WT and CYP46A1 KO mouse hippocampal slices. Data from LC-MS analysis showed that average 24S-HC level in freshly isolated hippocampus is significantly lower in KO (1.8 ± 0.2 ng/mg protein; N = 3) than in WT (385.0 ± 11.6 ng/mg protein; N = 3; Fig. 1A, P < 0.001), suggesting that, as expected (Lund et al. 2003; Meljon et al. 2014; Russell et al. 2009), endogenous 24S-HC level is greatly reduced in the KO mice. The estimated concentration of endogenous 24S-HC level in WT hippocampus was in the tens of micromolar, sufficient to modulate NMDAR function, assuming homogeneous distribution of the oxysterol (Paul et al. 2013). The results showed a slightly lower level of 24S-HC in WT slices than in intact WT tissue; however, 24S-HC was still much higher in WT slices (326.0 ± 16.2 ng/mg protein; N = 3) than in KO slices (2.0 ± 0.5 ng/mg protein; N = 3; Fig. 1A, P < 0.001), suggesting retention of high 24S-HC levels despite continuous perfusion of slices (Fig. 1A). This is consistent with strong retention of 24S-HC in cells (Paul et al. 2013) but could also imply ongoing synthesis. The observation that slices have nearly the same 24S-HC concentration as fresh tissue implies that slices are an appropriate model for exploring the potential role of endogenous 24S-HC in regulating NMDAR function.
Fig. 1.
Decreased N-methyl-d-aspartate receptor (NMDAR) positive tone in CYP46A1 knockout (KO) slices. A: endogenous 24S-hydroxycholesterol (24S-HC) was significantly reduced in KO tissue and slices [N = 3 wild-type (WT) and 3 KO animals; ***P < 0.001]. B: dual-component NMDAR and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) excitatory postsynaptic currents (EPSCs; red) were evoked in WT and KO slices at −30 mV. NMDAR EPSCs, measured 50 ms following peak EPSC, were completely blocked following 50 μM d-(−)-amino-5-phosphonopentanoic acid (d-APV) application (black). AMPAR EPSC peak amplitude was calculated after d-APV application. C: NMDAR/AMPAR ratio was compared between WT and KO slices (N = 15 cells from WT and 9 cells from KO slices; *P < 0.05).
NMDAR EPSCs, tonic current, and NMDAR-induced spiking are reduced in CYP46A1 KO slices.
24S-HC and its analogs potentiate NMDAR activity when applied exogenously (Paul et al. 2013). However, the role of endogenous 24S-HC in modulating NMDAR activity has not been established. To address this, we first examined effects of endogenous 24S-HC on NMDAR tone, measured in evoked, dual-component EPSCs. CYP46A1 KO slices exhibited a significantly smaller NMDAR-to-AMPAR EPSC ratio than WT slices (Fig. 1, B and C), suggesting that reducing endogenous 24S-HC in KO slices dampens NMDAR function. The results further suggest that basal NMDAR contribution to EPSCs reflects not only glutamate and glycine coagonist presence, but also the presence of the positive allosteric modulator, 24S-HC.
Although the effect of CYP46A1 KO on NMDAR EPSCs was significant, it was not a strong effect. To confirm that endogenous 24S-HC modulates the basal NMDAR current tone, we examined whether tonic NMDAR current induced by ambient glutamate was also reduced in CYP46A1 KO slices. We reasoned that 24S-HC's modulatory effects may be more evident at the lower, ambient glutamate concentrations than that at saturating, synaptic concentrations (Linsenbardt et al. 2014). Consistent with this idea, addition of the glutamate transporter blocker TBOA for 6 min, in the presence of blockers of GABARs and AMPARs, induced larger currents in WT neurons than in KO neurons (Fig. 2, A–C). The contribution of NMDARs to these currents was verified with MK-801, an activation-dependent blocker of NMDARs.
Fig. 2.
Induced tonic NMDAR currents are smaller and represent decreased channel open probability in KO slices. A and B: WT and KO responses to dl-threo-β-Benzyloxyaspartic acid (TBOA; 50 μM) application in the presence of AMPAR and γ-aminobutyric acid receptor (GABAR) blockers {10 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) and 100 μM picrotoxin (PTX)}, followed by coapplication of 40 μM MK-801. The solid red line is a fit to a single-exponential decay. C: summary of TBOA induced current (N = 13 WT and 13 KO cells, *P < 0.05). D: time constant of current decay in the presence of MK-801 (n = 9 WT and 11 KO cells; **P < 0.01). The time constant was not obtainable in 4 WT and 2 KO cells due to a large, prolonged EPSC at the onset of MK-801 application or to seal loss in this subset of cells. Although the source of the contaminating current is not completely clear, it may represent network disinhibition upon initial MK-801 application.
MK-801 blocking rate is proportional to channel open probability (Huettner and Bean 1988; Rosenmund et al. 1995). Consistent with our interpretation that larger TBOA-induced currents in WT slices represent channel openings with higher open probability, we found that MK-801-induced blocking rate was faster in WT slices than in KO slices (Fig. 2D).
Although NMDARs play a limited role in basal synaptic transmission at voltages near the resting membrane potential (approximately −60 to −70 mV), the NMDAR contribution is amplified when neurons receive repetitive excitatory synaptic drive, resulting in persistent depolarization, relief from physiological Mg2+ block of the NMDAR channel, and increased participation of NMDARs in spike generation (reviewed in Hunt and Castillo 2012). To address whether loss of CYP46A1 and the associated reduced NMDAR contribution to EPSCs (Fig. 1) affect the role of NMDARs in driving spike firing, we current-clamped WT or KO neurons and adopted a repetitive synaptic stimulation protocol to elicit NMDAR dependent spiking. Trains of 10 pulses at 50 Hz were delivered to promote dual-component EPSPs with stimulation intensity adjusted to evoke 5–6 spikes (approximately half of the pulse number) for each cell at baseline (Fig. 3, A–C). Input/output curves verified that WT and KO cells produced similar maximum firing rates with saturated levels of synaptic stimulation (8.7 ± 0.3 for WT, 8.7 ± 0.4 for KO, Fig. 3D). Therefore, the criterion of 5–6 spikes at baseline represented ∼60–70% of maximum for both groups. After baseline recording of 10 sweeps, 50 μM d-APV was washed-in to block NMDAR-mediated EPSPs (Fig. 3, A, B, and E), and the same stimulus protocol and intensity used at baseline was applied again to evoke spiking. d-APV more strongly reduced spiking in WT cells than in KO cells (Fig. 3, A, B, and E), suggesting more NMDAR contribution to EPSP-spike generation in WT animals. These results are consistent with the reduced NMDAR synaptic tone in KO animals (Figs. 1 and 2).
Fig. 3.
NMDAR-induced spiking is reduced in CYP46A1 KO slices. A and B: excitatory postsynaptic potentials (EPSPs) and associated action potentials were evoked in WT (A) and KO (B) slices at −65 mV during a 10-pulse, 50-Hz presynaptic stimulus train. Neither NBQX nor d-APV was present at baseline. EPSPs were then reevoked with the same stimulus parameters after 50 μM d-APV wash-in. C: spike number at baseline in WT or KO neurons. D: input-output curve for spikes evoked by repetitive synaptic stimulation in WT and KO neurons at baseline. WT and KO neurons share similar maximum firing capacity at a saturated level of synaptic stimulation (N = 18 WT and 17 KO cells). E: normalized (after/before d-APV) spike number following d-APV wash-in showed a weaker d-APV effect on KO slices (N = 18 cells from WT and 17 cells from KO slices; *P < 0.05).
An exogenous analog demonstrates lack of saturation and specificity.
24S-HC appears to potentiate NMDAR activity at a unique binding site specific for oxysterols (Paul et al. 2013). To address whether the endogenous level of 24S-HC saturates this NMDAR binding site, the synthetic 24S-HC analog SGE-301 (10 μM) was bath-applied to slices after a stable 10 min baseline recording, and its effect on NMDAR function was examined. When overall drug effect across genotypes was evaluated, SGE-301 significantly potentiated NMDAR EPSCs, but there was no interaction between genotype and drug condition (Fig. 4, A and B). This suggests that SGE-301 potentiation was statistically indistinguishable in KO vs. WT slices and that the NMDAR allosteric site is therefore not saturated by endogenous 24S-HC despite estimated high levels of the oxysterol (Fig. 1A).
Fig. 4.
Endogenous 24S-HC does not saturate oxysterol-mediated potentiation, and is selective for NMDAR EPSCs. A: NMDAR EPSCs were evoked at −30 mV in WT and KO slices in the presence of 100 μM PTX and 10 μM NBQX. After a 10-min stable baseline was established (black traces), SGE-301 was bath-applied for 15–30 min. After 6 min of SGE-301 perfusion, potentiation of EPSCs had stabilized and was averaged from traces in the next 10 min (red traces). B: summary of SGE-301 (10 μM) effect in WT and KO slices. Data from 10–15 min following drug onset were averaged for each cell and expressed relative to the average baseline responses (10 min) before drug delivery. A two-way ANOVA and Bonferroni post hoc analysis revealed a significant effect of SGE-301 (df = 1; F = 7.8; *P < 0.01) but no effect of genotype and no significant interaction between genotype and drug. (N = 10 cells from WT and 10 cells from KO in DMSO group; N = 13 cells from WT and 14 cells from KO slices in SGE-301 group; df = 1; F = 0.8; P > 0.2). C: AMPAR EPSCs were evoked at −70 mV in KO slices in the presence of 100 μM PTX and 50 μM d-APV. After a 10 min stable baseline was established (black trace), SGE-301 was bath-applied for 15–30 min. Potentiation was measured after 6 min of SGE-301 perfusion (red trace). D: GABAR IPSCs were evoked at 0 mV in KO slices in the presence of 10 μM NBQX and 50 μM d-APV. After a 10-min stable baseline was established (black trace), SGE-301 was bath-applied for 15–30 min. Potentiation was measured after 6 min of SGE-301 perfusion (red trace). E: normalized (after/before) peak amplitude was compared for NMDAR, AMPAR, and GABAR PSCs after 6 min SGE-301 application (N = 14 cells for NMDAR, 7 cells for AMPAR, and 11 cells for GABAR; Wilcoxon test ***P < 0.001).
In hippocampal cultures, potentiation by 24S-HC and its analogs is selective for NMDARs, given that no potentiation of evoked AMPAR EPSCs or GABAR IPSCs was observed when the compounds were exogenously applied to WT neurons (Paul et al. 2013). However, selectivity has not been examined in situ or in the CYP46A1 null background, where saturation of putative sites by endogenous 24S-HC is not a concern. To address this, we studied effects of SGE-301 on AMPAR EPSCs and GABAR IPSCs in CYP46A1 KO slices, where potential effects of endogenous 24S-HC can be excluded. We found that, while significantly potentiating NMDAR EPSCs relative to baseline (Fig. 4, A and E), SGE-301 failed to potentiate AMPAR EPSCs (Fig. 4, C and E; Wilcoxon test; P > 0.2).
SGE-301 effects on GABAR IPSCs were more complex (Fig. 4, D and E). Overall, there was no significant change in IPSCs (Wilcoxon test, P > 0.05, N = 11). When one outlying cell exhibiting potentiation during SGE-301 presentation was excluded from analysis, we found a small but significant decrease (29.7 ± 4.4%, N = 10, Wilcoxon test, P < 0.01) in IPSC amplitude following 6 min application of SGE-301. However, analysis of the time course of IPSC depression in these cells revealed that IPSC depression was not clearly linked to SGE-301 application. Instead, IPSCs typically showed a gradual, time-dependent decrease, and this decrease did not differ from that observed in 7 KO cells treated with vehicle (DMSO) only. These IPSCs exhibited a 17.4 ± 8.7% depression over 6 min, not statistically different from the depression exhibited by SGE-301 (Mann-Whitney test, P > 0.2; data not shown). Thus we conclude that IPSCs exhibit time-dependent rundown but, like AMPAR EPSCs, show no evidence for SGE-301-related potentiation or inhibition.
Reducing endogenous 24S-HC does not affect neuronal intrinsic excitability or spontaneous transmission.
Increased neuronal intrinsic excitability has been reported in several GluN1 KO mouse models (Pagadala et al. 2013; Tatard-Leitman et al. 2015). This effect is apparently a homeostatic response to loss of the obligatory GluN1 subunit, without which NMDAR currents are eliminated. Other studies using sensory deprivation or pharmacological NMDAR block have also observed compensatory changes in intrinsic excitability and/or synaptic transmission (Fan et al. 2005; Turrigiano et al. 1994; Turrigiano and Nelson 2004; van Welie et al. 2004; Zhang and Linden 2003). It remains unclear whether the more subtle manipulation of altering NMDAR positive allosteric modulation also elicits homeostatic compensation from intrinsic conductances. To test this, we compared WT and KO responses to 500-ms current steps, ranging from 0 to 800 pA (Fig. 5, A and B). Neurons were current clamped to −74 mV prior to steps using a small bias current when needed. We found no significant difference in any of the parameters related to intrinsic excitability, including firing rates vs. injected current intensity, threshold of action potential firing, resting membrane potential with no injected bias current, or membrane resistance (Fig. 5, C–F). We conclude that loss of oxysterol positive allosteric modulation is not sufficiently severe to invoke homeostatic changes in excitability.
Fig. 5.
Intrinsic excitability is unaffected by CYP46A1 deletion. A and B: a 500-ms current pulse, ranging from 0 to 800 pA to evoke trains of action potentials, was injected into WT or KO neurons held at −74 mV. C: the number of spikes evoked by injected current at certain intensity was compared between WT and KO neurons. D–F: parameters related to intrinsic excitability, including threshold of action potential firing, resting membrane potential, and membrane resistance, were compared between WT and KO neurons (N = 21 WT cells and 18 KO cells, P > 0.1).
Increased spontaneous basal excitatory synaptic transmission has been reported in GluN1 KO mouse models (Pagadala et al. 2013; Tatard-Leitman et al. 2015), possibly arising as a result of altered intrinsic excitability or representing a separate homeostatic effect on transmission. To elucidate whether changing 24S-HC levels alters basal spontaneous synaptic transmission, we measured frequency of spontaneous EPSCs (sEPSCs) and IPSCs (sIPSCs) in individual neurons, and we compared the frequency ratio of sEPSCs to sIPSCs (E/I ratio) in WT vs. KO slices. sEPSCs and sIPSCs were recorded at holding potentials of −70 mV and 0 mV, respectively (Fig. 6, A and B). We observed no difference of sEPSC and sIPSC frequency and E/I ratio between WT and CYP46A1 KO neurons (Fig. 6C). Furthermore, no significant change of sEPSC amplitude was observed between WT and KO neurons (data not shown). Taken together, we find that loss of positive allosteric modulation is not sufficiently severe to invoke compensatory changes in intrinsic conductances or in spontaneous synaptic transmission.
Fig. 6.
Spontaneous transmission is not detectably altered in CYP46A1 KO slices. A and B: representative traces of sEPSCs and sIPSCs recorded from WT and KO neurons. C: frequency of sEPSC, sIPSC, and E/I ratio were compared between WT and KO neurons (N = 10 WT cells and 9 KO cells; P > 0.1).
Reducing endogenous 24S-HC does not affect LTP induction.
Impaired NMDAR-dependent LTP in CYP46A1 KO mice has been demonstrated previously in 5- to 8-wk-old mice (Kotti et al. 2006; Kotti et al. 2008; Russell et al. 2009). We compared LTP in slices prepared from 30-day-old WT and KO animals. Field EPSPs (fEPSPs) were evoked at 50% maximal level to obtain a stable 10 min baseline recording. Slices were then stimulated at 100 Hz for 1 s to induce LTP, after which the fEPSP was monitored for an additional 60 min. Surprisingly, KO slices exhibited LTP indistinguishable from LTP in WT slices (Fig. 7A), suggesting that endogenous 24S-HC is not necessary for LTP that is induced by tetanic stimulation. Thus it appears that basal NMDAR function in 30-day-old KO slices is sufficient for normal LTP induction.
Fig. 7.
NMDAR dependent LTP is unaltered, while synaptic depression induced by oxygen-glucose deprivation (OGD) is abrogated in CYP46A1 KO slices. A: field EPSPs (fEPSPs) were evoked at 50% maximal level. fEPSP slopes were compared before and after 100 Hz, 1 s tetanic stimulation in WT (open squares) and KO slices (open circles). At 60 min following tetanic stimulation, potentiation of fEPSPs was indistinguishable between WT and KO slices (N = 5 WT slices and 5 KO slices, P > 0.2). B: fEPSPs were evoked at 50% maximal level. fEPSP slopes were compared before/after 20 min OGD in WT (open squares) and KO slices (open circles), and KO slices treated with 1 μM SGE-301 before and during OGD for 40 min total (closed circles). OGD produced > 80% depression of fEPSPs (30′) from all the three groups. After 90 min OGD wash-out (120′), recovery of fEPSPs was significantly greater in KO slices, but not in WT slices or KO slices treated with 1 μM SGE-301 (N = 5 WT slices, 5 KO slices, and 5 KO slices treated with SGE-301. *P < 0.05; Kruskal-Wallis test and Dunn's post hoc analysis). Insets show representative traces from the various conditions at the indicated time points. Scale bar: 1 mV, 5 ms.
CYP46A1 KO slices exhibit higher resistance to OGD-induced synaptic depression.
Despite our results showing intact LTP in CYP46A1 KO slices, we found that tonic NMDAR currents, perhaps generated largely by extrasynaptic receptors, are strongly affected by 24S-HC deletion (Fig. 2). Such conditions may be met by pathophysiological overstimulation of NMDARs during ischemia in situ or by oxygen-glucose deprivation in vitro (Soria et al. 2014). Given that NMDAR overactivation participates in ischemia-mediated excitotoxicity and synaptic depression (Weilinger et al. 2013), and a form of NMDAR-dependent synaptic depression can be induced in response to oxygen deprivation (Izumi et al. 1998), we hypothesized that 24S-HC reduction may alter OGD-induced synaptic depression or its recovery. To test this hypothesis, we examined synaptic depression caused by 20 min OGD in hippocampal slices. Field EPSPs (fEPSPs) were evoked at 50% maximal level, and fEPSP slopes were compared before and after OGD in WT vs. KO slices. OGD resulted in >80% depression of fEPSPs from both WT and KO slices (30′). Ninety minutes following OGD wash-out (120′), recovery of fEPSPs was significantly greater in KO slices compared with WT slices (Fig. 7B), suggesting that reduction of 24S-HC protects neurotransmission from OGD-induced synaptic depression. To test if 24S-HC is likely responsible for the persistent synaptic depression in WT slices, we treated KO slices with 1 μM SGE-301 before and during OGD. Similar to WT slices, KO slices treated with SGE-301 exhibited fEPSP depression that failed to recover to the level observed from untreated KO slices after OGD wash-out (Fig. 7B). Thus acute application of SGE-301 on KO slices restores persistent OGD-induced synaptic depression observed in WT slices.
DISCUSSION
Our results revealed reduced NMDAR activity and function in mice lacking endogenous 24S-HC. We found evidence for decreased NMDAR contributions to evoked EPSCs, to TBOA-induced tonic currents, and to NMDAR-dependent action potential generation, and we found resistance to NMDAR-mediated synaptic depression during OGD when endogenous 24S-HC level is greatly reduced. These changes occur in a context in which overall synaptic transmission and intrinsic excitability are not detectably altered. This pattern of results suggests that endogenous 24S-HC contributes to NMDAR-dependent transmission in both physiological and pathophysiological conditions. The findings suggest some optimism for the strategy of therapeutic manipulation of 24S-HC levels, which minimizes collateral side effects.
One possible interpretation of our main finding could be that altered NMDAR function is a secondary consequence of CYP46A1 deletion, resulting perhaps from altered cholesterol levels or from transcriptional or posttranscriptional effects of the oxysterol (Hong and Tontonoz 2014; Maioli et al. 2013; Wang et al. 2002) and a consequent reduction in NMDAR expression or fewer functional synaptic NMDARs. Previous study of CYP46A1 knockout animals revealed no overall changes in cholesterol levels, attributed to feedback regulation of cholesterol synthesis (Lund et al. 2003; Meljon et al. 2014; Russell et al. 2009). CYP46A1 KO mice are outwardly normal without significant changes in physiological measures compared with WT mice (Lund et al. 2003). CYP46A1 KO mice exhibit normal cellular architecture of the hippocampus, indistinguishable synapse morphology compared with WT mice, and unchanged endogenous GluN1 levels (Kotti et al. 2006). Our own results suggest no impairment of AMPAR EPSCs and GABAR IPSCs or alteration in excitability (see below). Furthermore, MK-801 blocking rates of tonic NMDAR currents are slower in KO slices than in WT (Fig. 2D), supporting our hypothesis that channel open probability (Emnett et al. 2015; Huettner and Bean 1988; Rosenmund et al. 1995), not receptor number, is the major difference between WT and KO cells. Although we cannot fully exclude more complicated explanations of reduced NMDAR EPSCs in KO mice, the most parsimonious explanation of reduced NMDAR function consistent with known acute effects of 24S-HC (Linsenbardt et al. 2014; Paul et al. 2013) is that NMDARs in KO slices show reduced positive allosteric tone.
NMDAR-dependent spiking was reduced in 24S-HC deficient slices, consistent with the reduced NMDAR EPSCs. NMDARs play essential roles in information processing in the brain, and their contribution is frequency-dependent, as a result of physiological Mg2+ block of the channel (Daw et al. 1993; Herron et al. 1986; Hunt and Castillo 2012). The slow decay and voltage-dependent activation of NMDAR EPSCs contribute to temporal summation of EPSPs and resultant spike generation following repetitive synaptic activity (Augustinaite and Heggelund 2007; Dingledine et al. 1986). Therefore, NMDARs integrate synaptic inputs (Larkum and Nevian 2008), promote recurrent excitation of cortical networks (Wang et al. 2008), and generate persistent activity of neural assemblies (Hunt and Castillo 2012; Major and Tank 2004). In the present study, KO cell spiking showed reduced sensitivity to d-APV (Fig. 3, A–E), suggesting that the relatively small changes in NMDAR tone translate into functionally relevant effects on activity.
NMDARs have important long-term effects on synaptic development, pruning, and plasticity of established synapses (Cohen and Greenberg 2008; Hunt and Castillo 2012; Sanz-Clemente et al. 2013). Therefore, it may be surprising that we failed to observe evidence for compensatory or Hebbian effects of 24S-HC loss on spontaneous transmission and/or intrinsic excitability (Figs. 5 and 6). Also surprising is the lack of effect of 24S-HC reduction on LTP induction in slices (Fig. 7A). A recent study showed that forebrain-selective GluN1 deletion altered basal synaptic transmission and intrinsic excitability of CA1 neurons (Tatard-Leitman et al. 2015). Furthermore, NMDAR activation has been associated with changes in intrinsic excitability (Zhang and Linden 2003), as well as triggering AMPAR insertion underlying LTP (Malinow and Malenka 2002). On the other hand, blocking NMDARs is not a particularly effective trigger for homeostatic plasticity (Turrigiano and Nelson 2004), and our results in slices suggested no effect of 24S-HC reduction on evoked LTP (Fig. 7A). Overall, our inability to detect secondary changes in transmission, excitability, or LTP may arise from the weaker NMDAR manipulation in our study than in other studies. For instance, forebrain GluN1 deletion will cause complete loss of NMDAR function in affected regions. A role of 24S-HC in LTP induction may only be evident in older animals or under certain stimulation protocols (Kotti et al. 2006; Kotti et al. 2008). Thus we propose that mild manipulation of NMDARs by allosteric modulation in our study prevented strong compensatory changes and is consistent with the relatively mild phenotype for KO animals (Kotti et al. 2006; Russell et al. 2009).
Enhancing NMDAR activity is a potential treatment strategy for schizophrenia (Hashimoto 2014) and for age-related dementia (Burgdorf et al. 2011). Interestingly, elevating endogenous levels of 24S-HC has been reported effective for improving learning and memory deficits associated with aging (Maioli et al. 2013), suggesting a possible link between 24S-HC level and NMDAR function/activity. However, it is unclear whether increasing endogenous 24S-HC levels would be an effective treatment if 24S-HC modulatory sites on NMDARs are fully occupied. Our results suggest that in the ex vivo slice, sites are not fully occupied, as indicated by SGE-301 potentiation of NMDAR function in WT tissue (Fig. 4). This suggests that endogenous 24S-HC does not saturate NMDARs in situ. A possible explanation for this finding is that a certain amount of 24S-HC may be lost during slice preparation. However, the endogenous 24S-HC level, when measured from WT hippocampal slices (326.0 ± 16.2 ng/mg protein; Fig. 1A), was similar to fresh tissue (385.0 ± 11.6 ng/mg protein; Fig. 1A). Our measured levels were also similar to previously reported measurements from freshly prepared brain tissues (30–60 ng/mg total tissue in adult mice brain) (Griffiths and Wang 2011; Karu et al. 2007; Meljon et al. 2012), assuming protein is ∼10% of tissue weight. Overall, our slice measurements suggest that net loss of 24S-HC with slice preparation and perfusion is not a concern in our experimental conditions and that 24S-HC is retained and/or synthesized locally for up to 5–6 h ex vivo. The lack of functional saturation in the context of high tissue 24S-HC levels suggests that a large fraction of 24S-HC may be sequestered and not active at NMDARs. An implication of the lack of saturation is that compounds like SGE-301, with selective potentiating effects at NMDARs (Fig. 4), may be effective drug candidates (Paul et al. 2013).
Downregulation of oxysterol function also may have therapeutic potential, for instance in stroke. NMDAR-mediated excitotoxicity is a major outcome of the bioenergetic failure associated with stroke (reviewed in Hardingham and Bading 2010). Unfortunately, clinical trials aimed at directly inhibiting/blocking NMDARs have not experienced much success due to multiple undesired side effects (Muir 2006). Here, we found that KO slices exhibited improved recovery of synaptic transmission from NMDAR-dependent, OGD-induced synaptic depression (Fig. 7B), suggesting potential therapeutic benefit of 24S-HC reduction. This beneficial effect was prevented by slice pretreatment with a 24S-HC analog, suggesting that levels of endogenous 24S-HC directly modulate NMDAR-mediated synaptic depression in WT tissue. Approaches for reducing endogenous 24S-HC effects on NMDARs might include targeting CYP46A1 function genetically or pharmacologically (Mast et al. 2010; Shafaati et al. 2010), although both shRNA and pharmacological inhibition of CYP46A1 have yielded secondary consequences that would have to be addressed in a therapeutic setting (Chali et al. 2015; Fourgeux et al. 2014). An alternative approach is to directly antagonize endogenous 24S-HC's positive allosteric effects on NMDARs (Linsenbardt et al. 2014). Taken together, our findings suggest that reducing 24S-HC's action on NMDARs may offer a novel therapeutic approach for conditions involving NMDAR overactivity.
In summary, results from this study support the hypothesis that endogenous 24S-HC selectively modulates NMDAR function. We find little evidence for secondary consequences of either genetic CYP46A1 deletion or of the reduced positive NMDAR tone. Our evidence suggests that the endogenous oxysterol site is not saturated by endogenous 24S-HC levels, so that upregulation and downregulation of 24S-HC levels may be used endogenously to govern normal NMDAR-dependent plasticity, and both upregulation and downregulation might represent viable therapeutic strategies.
GRANTS
This work was supported by the Bantly Foundation and by National Institutes of Health (NIH) Grants R01-AA-017413, R01-MH-077791, R01-MH-078823, R01-MH-101874, and R21-MH-104506 (S. Mennerick), and by Washington University McDonnell Center for Cellular and Molecular Neurobiology postdoctoral fellowship (M.-Y. Sun). Mass spectrometry analyses were performed in the Metabolomics Facility at Washington University (NIH Grant P30-DK-020579).
DISCLOSURES
C. F. Zorumski is a member of the Scientific Advisory Board for Sage Therapeutics and holds equity in Sage Therapeutics. Washington University in St. Louis has licensed technology to Sage Therapeutics. The research herein was not supported by or licensed to Sage Therapeutics.
AUTHOR CONTRIBUTIONS
Author contributions: M.-Y.S., Y.I., C.F.Z., and S.M. conception and design of research; M.-Y.S., Y.I., and A.B. performed experiments; M.-Y.S., Y.I., A.B., and S.M. analyzed data; M.-Y.S., Y.I., C.F.Z., and S.M. interpreted results of experiments; M.-Y.S., Y.I., and S.M. prepared figures; M.-Y.S. and S.M. drafted manuscript; M.-Y.S., Y.I., C.F.Z., and S.M. edited and revised manuscript; M.-Y.S., Y.I., C.F.Z., and S.M. approved final version of manuscript.
ACKNOWLEDGMENTS
We thank Sage Therapeutics for the gift of SGE-301.
REFERENCES
- Augustinaite S, Heggelund P. Changes in firing pattern of lateral geniculate neurons caused by membrane potential dependent modulation of retinal input through NMDA receptors. J Physiol 582: 297–315, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benarroch EE. Neurosteroids: endogenous modulators of neuronal excitability and plasticity. Neurology 68: 945–947, 2007. [DOI] [PubMed] [Google Scholar]
- Burgdorf J, Zhang XL, Weiss C, Matthews E, Disterhoft JF, Stanton PK, Moskal JR. The N-methyl-d-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats. Neurobiol Aging 32: 698–706, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chali F, Djelti F, Eugene E, Valderrama M, Marquer C, Aubourg P, Duykaerts C, Miles R, Cartier N, Navarro V. Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus. Eur J Neurosci 41: 1345–1355, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen S, Greenberg ME. Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu Rev Cell Dev Biol 24: 183–209, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coyle JT. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26: 365–384, 2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coyle JT, Balu D, Benneyworth M, Basu A, Roseman A. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues Clin Neurosci 12: 359–382, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danysz W, Parsons CG. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine–searching for the connections. Br J Pharmacol 167: 324–352, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daw NW, Stein PS, Fox K. The role of NMDA receptors in information processing. Annu Rev Neurosci 16: 207–222, 1993. [DOI] [PubMed] [Google Scholar]
- Dingledine R, Hynes MA, King GL. Involvement of N-methyl-d-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J Physiol 380: 175–189, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emnett CM, Eisenman LN, Mohan J, Taylor AA, Doherty JJ, Paul SM, Zorumski CF, Mennerick S. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel. Br J Pharmacol 172: 1333–1347, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fan Y, Fricker D, Brager DH, Chen X, Lu HC, Chitwood RA, Johnston D. Activity-dependent decrease of excitability in rat hippocampal neurons through increases in I(h). Nat Neurosci 8: 1542–1551, 2005. [DOI] [PubMed] [Google Scholar]
- Flood JF, Morley JE, Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 89: 1567–1571, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fourgeux C, Martine L, Acar N, Bron AM, Creuzot-Garcher CP, Bretillon L. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina. Biochem Biophys Res Commun 446: 775–781, 2014. [DOI] [PubMed] [Google Scholar]
- Ghasemi M, Schachter SC. The NMDA receptor complex as a therapeutic target in epilepsy: a review. Epilepsy Behav 22: 617–640, 2011. [DOI] [PubMed] [Google Scholar]
- Griffiths WJ, Wang Y. Analysis of oxysterol metabolomes. Biochim Biophys Acta 1811: 784–799, 2011. [DOI] [PubMed] [Google Scholar]
- Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11: 682–696, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hashimoto K. Targeting of NMDA receptors in new treatments for schizophrenia. Expert Opin Ther Targets 18: 1049–1063, 2014. [DOI] [PubMed] [Google Scholar]
- Herron CE, Lester RA, Coan EJ, Collingridge GL. Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature 322: 265–268, 1986. [DOI] [PubMed] [Google Scholar]
- Hestrin S, Nicoll RA, Perkel DJ, Sah P. Analysis of excitatory synaptic action in pyramidal cells using whole-cell recording from rat hippocampal slices. J Physiol 422: 203–225, 1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov 13: 433–444, 2014. [DOI] [PubMed] [Google Scholar]
- Huettner JE, Bean BP. Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85: 1307–1311, 1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hunt DL, Castillo PE. Synaptic plasticity of NMDA receptors: mechanisms and functional implications. Curr Opin Neurobiol 22: 496–508, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Izumi Y, Katsuki H, Benz AM, Zorumski CF. Oxygen deprivation produces delayed inhibition of long-term potentiation by activation of NMDA receptors and nitric oxide synthase. J Cereb Blood Flow Metab 18: 97–108, 1998. [DOI] [PubMed] [Google Scholar]
- Karu K, Hornshaw M, Woffendin G, Bodin K, Hamberg M, Alvelius G, Sjovall J, Turton J, Wang Y, Griffiths WJ. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J Lipid Res 48: 976–987, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kotti T, Head DD, McKenna CE, Russell DW. Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. Proc Natl Acad Sci USA 105: 11394–11399, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kotti TJ, Ramirez DM, Pfeiffer BE, Huber KM, Russell DW. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci USA 103: 3869–3874, 2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol 115: 157–188, 2014. [DOI] [PubMed] [Google Scholar]
- Larkum ME, Nevian T. Synaptic clustering by dendritic signalling mechanisms. Curr Opin Neurobiol 18: 321–331, 2008. [DOI] [PubMed] [Google Scholar]
- Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8: 413–426, 2007. [DOI] [PubMed] [Google Scholar]
- Liere P, Pianos A, Eychenne B, Cambourg A, Bodin K, Griffiths W, Schumacher M, Baulieu EE, Sjovall J. Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key. J Lipid Res 50: 2430–2444, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Linsenbardt AJ, Taylor A, Emnett CM, Doherty JJ, Krishnan K, Covey DF, Paul SM, Zorumski CF, Mennerick S. Different oxysterols have opposing actions at N-methyl-d-aspartate receptors. Neuropharmacology 85: 232–242, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lund EG, Xie C, Kotti T, Turley SD, Dietschy JM, Russell DW. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem 278: 22980–22988, 2003. [DOI] [PubMed] [Google Scholar]
- Maioli S, Bavner A, Ali Z, Heverin M, Ismail MA, Puerta E, Olin M, Saeed A, Shafaati M, Parini P, Cedazo-Minguez A, Bjorkhem I. Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain? PLoS One 8: e68534, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Major G, Tank D. Persistent neural activity: prevalence and mechanisms. Curr Opin Neurobiol 14: 675–684, 2004. [DOI] [PubMed] [Google Scholar]
- Malinow R, Malenka RC. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25: 103–126, 2002. [DOI] [PubMed] [Google Scholar]
- Mast N, Charvet C, Pikuleva IA, Stout CD. Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. J Biol Chem 285: 31783–31795, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mathis C, Paul SM, Crawley JN. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology (Berl) 116: 201–206, 1994. [DOI] [PubMed] [Google Scholar]
- Meljon A, Theofilopoulos S, Shackleton CH, Watson GL, Javitt NB, Knolker HJ, Saini R, Arenas E, Wang Y, Griffiths WJ. Analysis of bioactive oxysterols in newborn mouse brain by LC/MS. J Lipid Res 53: 2469–2483, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meljon A, Wang Y, Griffiths WJ. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse. Biochem Biophys Res Commun 446: 768–774, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muir KW. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol 6: 53–60, 2006. [DOI] [PubMed] [Google Scholar]
- Pagadala P, Park CK, Bang S, Xu ZZ, Xie RG, Liu T, Han BX, Tracey WD Jr, Wang F, Ji RR. Loss of NR1 subunit of NMDARs in primary sensory neurons leads to hyperexcitability and pain hypersensitivity: involvement of Ca2+-activated small conductance potassium channels. J Neurosci 33: 13425–13430, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14: 383–400, 2013. [DOI] [PubMed] [Google Scholar]
- Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, Hammond RS, Crawford DC, Linsenbardt AJ, Shu HJ, Izumi Y, Mennerick SJ, Zorumski CF. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-d-aspartate receptors. J Neurosci 33: 17290–17300, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paul SM, Purdy RH. Neuroactive steroids. FASEB J 6: 2311–2322, 1992. [PubMed] [Google Scholar]
- Rosenmund C, Feltz A, Westbrook GL. Synaptic NMDA receptor channels have a low open probability. J Neurosci 15: 2788–2795, 1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Russell DW, Halford RW, Ramirez DM, Shah R, Kotti T. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu Rev Biochem 78: 1017–1040, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanz-Clemente A, Nicoll RA, Roche KW. Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist 19: 62–75, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shafaati M, Mast N, Beck O, Nayef R, Heo GY, Bjorkhem-Bergman L, Lutjohann D, Bjorkhem I, Pikuleva IA. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo. J Lipid Res 51: 318–323, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sliwinski A, Monnet FP, Schumacher M, Morin-Surun MP. Pregnenolone sulfate enhances long-term potentiation in CA1 in rat hippocampus slices through the modulation of N-methyl-d-aspartate receptors. J Neurosci Res 78: 691–701, 2004. [DOI] [PubMed] [Google Scholar]
- Smith CC, Gibbs TT, Farb DH. Pregnenolone sulfate as a modulator of synaptic plasticity. Psychopharmacology (Berl) 231: 3537–3556, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith LL, Ray DR, Moody JA, Wells JD, Van Lier JE. 24-hydroxycholesterol levels in human brain. J Neurochem 19: 899–904, 1972. [DOI] [PubMed] [Google Scholar]
- Soria FN, Perez-Samartin A, Martin A, Gona KB, Llop J, Szczupak B, Chara JC, Matute C, Domercq M. Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J Clin Invest 124: 3645–3655, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tamminga CA. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12: 21–36, 1998. [DOI] [PubMed] [Google Scholar]
- Tatard-Leitman VM, Jutzeler CR, Suh J, Saunders JA, Billingslea EN, Morita S, White R, Featherstone RE, Ray R, Ortinski PI, Banerjee A, Gandal MJ, Lin R, Alexandrescu A, Liang Y, Gur RE, Borgmann-Winter KE, Carlson GC, Hahn CG, Siegel SJ. Pyramidal cell selective ablation of N-methyl-d-aspartate receptor 1 causes increase in cellular and network excitability. Biol Psychiatry 77: 556–568, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turrigiano G, Abbott LF, Marder E. Activity-dependent changes in the intrinsic properties of cultured neurons. Science 264: 974–977, 1994. [DOI] [PubMed] [Google Scholar]
- Turrigiano GG, Nelson SB. Homeostatic plasticity in the developing nervous system. Nat Rev Neurosci 5: 97–107, 2004. [DOI] [PubMed] [Google Scholar]
- Vallee M, Mayo W, Koob GF, Le Moal M. Neurosteroids in learning and memory processes. Int Rev Neurobiol 46: 273–320, 2001a. [DOI] [PubMed] [Google Scholar]
- Vallee M, Mayo W, Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Brain Res Rev 37: 301–312, 2001b. [DOI] [PubMed] [Google Scholar]
- van Welie I, van Hooft JA, Wadman WJ. Homeostatic scaling of neuronal excitability by synaptic modulation of somatic hyperpolarization-activated Ih channels. Proc Natl Acad Sci USA 101: 5123–5128, 2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, Lichnerova K, Cerny J, Krusek J, Dittert I, Horak M, Vyklicky L. Structure, function, and pharmacology of NMDA receptor channels. Physiol Res 63, Suppl 1: S191–S203, 2014. [DOI] [PubMed] [Google Scholar]
- Wang H, Stradtman GG 3rd, Wang XJ, Gao WJ. A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proc Natl Acad Sci USA 105: 16791–16796, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson JA. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc Natl Acad Sci USA 99: 13878–13883, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weilinger NL, Maslieieva V, Bialecki J, Sridharan SS, Tang PL, Thompson RJ. Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction. Acta Pharmacol Sin 34: 39–48, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Mol Pharmacol 40: 333–336, 1991. [PubMed] [Google Scholar]
- Yamakura T, Shimoji K. Subunit- and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 59: 279–298, 1999. [DOI] [PubMed] [Google Scholar]
- Zhang W, Linden DJ. The other side of the engram: experience-driven changes in neuronal intrinsic excitability. Nat Rev Neurosci 4: 885–900, 2003. [DOI] [PubMed] [Google Scholar]







